Home
SK Bioscience Co. Ltd.

SK Bioscience Co. Ltd. Market Share Analysis for April 2026

백신/바이오의 혁신적 글로벌 파트너 SK 바이오사이언스 From Prevention To Cure

Jobs and Career > Jobs and Career - Other

Domainskbioscience.com

Year Founded2018

Employees1001 - 5000

Annual Revenue--

SK Bioscience Co. Ltd.

SK Bioscience Co. Ltd. (including company regionals)

skbioscience.com

See more website traffic and engagement information

Total visits to SK Bioscience Co. Ltd.'s top domains

Understand SK Bioscience Co. Ltd. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

skbioscience.com21.6K

See more with Sales Intelligence

Avg. visit duration in SK Bioscience Co. Ltd.'s top domains

Analyze SK Bioscience Co. Ltd. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

skbioscience.com00:02:15

See more with Sales Intelligence

Avg. pageviews on SK Bioscience Co. Ltd.'s top domains

See how SK Bioscience Co. Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

skbioscience.com3.19

See more with Sales Intelligence

SK Bioscience Co. Ltd. top competitors by domain

Top similar sites in April 2026, ranked by their affinity

valneva.comCompany NameValnevaEmployees501 - 1000HQFrance, Saint-HerblainAnnual revenue$100M - $200MTotal visits40.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by SK Bioscience Co. Ltd.

These are the website technologies, by industry, used by SK Bioscience Co. Ltd. top domains

Advertising (3)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Audio Video Media (1)

YouTube

Marketing (1)

Google Marketing Platform

More Technologies

4

See all

News & Signals from SK Bioscience Co. Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSK Bioscience is developing vaccination approaches."By working with SK bioscience and Vaxxas to advance needle-free patch technology for influenza vaccines, we are helping to develop new vaccination approaches designed to better protect people around the world against seasonal and pandemic influenza.

NewsSK Bioscience partnered with Vaxxas, Inc. on Jan 1st '11.SK bioscience will also collaborate with Vaxxas for the clinical development, with Vaxxas manufacturing HD-MAP vaccines.

NewsSK Bioscience is developing RSM01.SK Boscience revealed an exclusive licensing agreement with the Gates Medical Research Institute (Gates MRI) granting SK rights to develop and commercialize RSM01, a clinical-stage respiratory syncytial virus (RSV) preventive monoclonal antibody (mAb) candidate, with specified global access commitments and differentiated supply terms across income markets.